Cancer Scientist: This Common Daily Diet May Be Feeding Cancer!

Cancer originates from chronic damage to the mitochondria, the cell's energy-producing organelle, which forces cells to abandon efficient oxidative phosphorylation in favor of ancient, unbridled fermentation. Professor Thomas Seyfried explains that this metabolic shift, driven by glucose and glutamine, fuels the dysregulated growth characteristic of cancer. By utilizing the Glucose Ketone Index (GKI) as a biomarker, individuals can monitor their metabolic state to maintain a "zone of prevention," where low blood sugar and elevated ketones protect healthy cells. Metabolic therapies, such as ketogenic diets and fasting, starve tumor cells of their essential fuels, making them more vulnerable to lower, less toxic doses of conventional treatments. This approach shifts the focus from purely genetic models of cancer to a bioenergetic framework, offering a strategy to manage the disease by restoring mitochondrial health and systemic homeostasis.